332 related articles for article (PubMed ID: 23538190)
1. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
Wong CK; Lam CL; Wan YF; Rowen D
Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
[TBL] [Abstract][Full Text] [Related]
2. Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.
Wong CK; Lam CL; Rowen D; McGhee SM; Ma KP; Law WL; Poon JT; Chan P; Kwong DL; Tsang J
Value Health; 2012 May; 15(3):495-503. PubMed ID: 22583460
[TBL] [Abstract][Full Text] [Related]
3. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
4. Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients.
Ameri H; Yousefi M; Yaseri M; Nahvijou A; Arab M; Akbari Sari A
J Gastrointest Cancer; 2020 Mar; 51(1):196-203. PubMed ID: 30977049
[TBL] [Abstract][Full Text] [Related]
5. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
Grande GE; Farquhar MC; Barclay SI; Todd CJ
Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
[TBL] [Abstract][Full Text] [Related]
6. Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients.
Ameri H; Yousefi M; Yaseri M; Nahvijou A; Arab M; Akbari Sari A
Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):89-96. PubMed ID: 30173585
[TBL] [Abstract][Full Text] [Related]
7. Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country.
Yousefi M; Nahvijou A; Sari AA; Ameri H
Value Health Reg Issues; 2021 May; 24():57-66. PubMed ID: 33508752
[TBL] [Abstract][Full Text] [Related]
8. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
Richardson SS; Berven S
Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
[TBL] [Abstract][Full Text] [Related]
9. Predicting health-utility scores from the Cervical Spine Outcomes Questionnaire in a multicenter nationwide study of anterior cervical spine surgery.
Skolasky RL; Carreon LY; Anderson PA; Albert TJ; Riley LH
Spine (Phila Pa 1976); 2011 Dec; 36(25):2211-6. PubMed ID: 21343870
[TBL] [Abstract][Full Text] [Related]
10. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
[TBL] [Abstract][Full Text] [Related]
11. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
Lamu AN; Olsen JA
Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
[TBL] [Abstract][Full Text] [Related]
12. Mapping the Gastrointestinal Quality of Life Index to short-form 6D utility scores.
Lee L; Kaneva P; Latimer E; Feldman LS
J Surg Res; 2014 Jan; 186(1):135-41. PubMed ID: 24021906
[TBL] [Abstract][Full Text] [Related]
13. The potential for a generally applicable mapping model between QLQ-C30 and SF-6D in patients with different cancers: a comparison of regression-based methods.
Kontodimopoulos N
Qual Life Res; 2015 Jun; 24(6):1535-44. PubMed ID: 25391489
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires.
Pezzilli R; Morselli-Labate AM; Fantini L; Campana D; Corinaldesi R
Dig Liver Dis; 2007 Dec; 39(12):1077-86. PubMed ID: 17692582
[TBL] [Abstract][Full Text] [Related]
15. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 quality of life questionnaires for patients with colorectal cancer: a literature review.
Ganesh V; Agarwal A; Popovic M; Cella D; McDonald R; Vuong S; Lam H; Rowbottom L; Chan S; Barakat T; DeAngelis C; Borean M; Chow E; Bottomley A
Support Care Cancer; 2016 Aug; 24(8):3661-8. PubMed ID: 27193118
[TBL] [Abstract][Full Text] [Related]
17. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
18. Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.
Liu T; Li S; Wang M; Sun Q; Chen G
Patient; 2020 Oct; 13(5):537-555. PubMed ID: 32382953
[TBL] [Abstract][Full Text] [Related]
19. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
20. A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire.
Pickard AS; Shaw JW; Lin HW; Trask PC; Aaronson N; Lee TA; Cella D
Value Health; 2009 Sep; 12(6):977-88. PubMed ID: 19402850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
